Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T: A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study

NCT06673056 is registered in ClinicalTrials.gov with IntraBio Inc as lead sponsor.

NCT NCT06673056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06673056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T: A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study
Lead sponsor
IntraBio Inc
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 18, 2025
Completion date
June 1, 2028
Enrollment
60 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia-telangiectasia, ataxia-telangiectasia (a-t)